GLP-1 Daily: Ozempic & Wegovy News

Wegovy Across Borders: Korea Eases Imports, Aspen Gets Generic Approvals

Thursday, November 12, 2026 · 6 min

GLP-1 Daily: Ozempic & Wegovy News cover art

South Korea now lets travelers bring home legally prescribed Wegovy and Mounjaro from abroad, while Aspen reports generic semaglutide approvals in Brazil and South Africa. Access is widening, but launch dates and patent limits still matter; ask your prescriber how these developments affect your treatment options.

Listen

Listen to the audio episode

Read the episode transcript

Show notes

South Korea now lets travelers bring home legally prescribed Wegovy and Mounjaro from abroad, while Aspen reports generic semaglutide approvals in Brazil and South Africa. Access is widening, but launch dates and patent limits still matter; ask your prescriber how these developments affect your treatment options.

In this episode

  1. Korea's contradictory weight-loss policy sends mixed signals | Aju Press — Aju Press
    “From Thursday, travelers may carry in prescribed obesity drugs such as Novo Nordisk's Wegovy and Eli Lilly's Mounjaro, the Ministry of Food and Drug Safety (MFDS) said. The medicines must be approved by the relevant country's regulator and legally prescribed and purchased. The…”
  2. Aspen gets go-ahead to produce generic Ozempic and Wegovy — Bizcommunity
    “South African pharmaceutical company Aspen Pharmacare said it had received regulatory approval in Brazil and South Africa for its generic injectable semaglutide, paving the way for launches in two key emerging markets.”
  3. ‎Avalon’s Generic Mounjaro Is Not Yet Saudi-Made - Saudiweek. — Saudiweek
    “Avalon Pharma has put a large number on its licence to sell a generic version of tirzepatide, the drug Eli Lilly markets as Mounjaro and Zepbound. It has not put a date on it. The details point to a long wait, and a longer one for tirzepatide made in Saudi Arabia.”